Published TCIMAIL newest issue No.200
Maximum quantity allowed is 999
*Lagerbestand in Belgien: Versand am selben Tag
*Lagerbestand in Japan: Bitte prüfen Sie die Versandsimulation für voraussichtliche Lieferzeiten. (ausgenommen regulierte Produkte und Trockeneissendungen)
This product is intended for research and development purposes only. It may not be used for (i) any human or veterinary use, including without limitation therapeutic and prophylactic use, (ii) any clinical use, including without limitation diagnostic use. Any use of this product for any of the above mentioned purposes requires a license from the Massachusetts Institute of Technology.
List of Patent Applications and Patents (PDF)
| Artikel # | D5038 |
Reinheit / Analysenmethode
|
>98.0%(GC) |
| Summenformel / Molekülmasse | C__3__3H__4__9P = 476.73 |
| Physikalischer Zustand (20 °C) | Solid |
Lagerungstemperatur
|
Room Temperature (Recommended in a cool and dark place, <15°C) |
Verpackung und Behälter
|
1G-Glass Bottle with Plastic Insert (Bild ansehen) |
| CAS RN | 564483-18-7 |
| Reaxys Registrierungsnummer | 9448497 |
| PubChem-Stoff-ID | 354334782 |
| MDL-Nummer | MFCD04117682 |
| Appearance | White to Almost white powder to crystal |
| Purity(GC) | min. 98.0 % |
| Melting point | 186.0 to 190.0 °C |
| Schmelzpunkt | 186 °C |
| Löslichkeit (löslich in) | Chloroform |
| Piktogramm |
|
| Signalwort | Achtung |
| Gefahrenhinweise | H315 : Verursacht Hautreizungen. H319 : Verursacht schwere Augenreizung. |
| Sicherheitshinweise | P264 : Nach Gebrauch Haut gründlich waschen. P280 : Schutzhandschuhe/ Augenschutz/ Gesichtsschutz tragen. P302 + P352 : BEI BERÜHRUNG MIT DER HAUT: Mit viel Wasser waschen. P337 + P313 : Bei anhaltender Augenreizung: Ärztlichen Rat einholen/ ärztliche Hilfe hinzuziehen. P362 + P364 : Kontaminierte Kleidung ausziehen und vor erneutem Tragen waschen. P332 + P313 : Bei Hautreizung: Ärztlichen Rat einholen/ ärztliche Hilfe hinzuziehen. |
| HS-Nr. (Import / Export) (TCI-E) | 2931498090 |

1,4-Dichlorobenzene (500 mg, 3.40 mmol) and piperidine (869 mg, 10.2 mmol) were dissolved in degassed toluene (15.0 mL). To this solution was added sodium tert-butoxide (817 mg, 8.50 mmol), XPhos (65 mg, 0.136 mmol, 4 mol%) and Pd2(dba)3 (47 mg, 0.051 mmol, 1.5 mol%). The reaction was refluxed for 16 h and quenched with H2O (15 mL) after cooling to room temperature. The organic phase was separated and washed with H2O (10 mL) and brine (10 mL), dried over Na2SO4 (30 g), concentrated under reduced pressure to afford the crude product as brown solid, which was purified by column chromatography on silica gel (CH2Cl2 100% → CH2Cl2: EtOAc = 30: 70) to afford the product 1 as a pale yellow solid. The obtained solid was dissolved in hexane and decolorized by activated carbon. After removal of activated carbon by filtration, the filtrate was concentrated to afford the product 1 as a white powder (782 mg, 2.66 mmol, 78%).
Toluene was degassed by refluxing under nitrogen atmosphere.
Completion of the reaction was confirmed by HPLC.
Obtained product was colorized gradually by the exposure of air and light.
1H NMR (400 MHz, CDCl3); δ 6.92 (s, 4H), 2.92 (t, J = 5.9, 8H), 1.54 (m, 8H), 1.32 (m, 4H).

To a solution of palladium(II) acetate (44.9 mg, 0.200 mmol, 4 mol%), XPhos (143 mg, 0.300 mmol, 6 mol%), cesium fluoride (2.28 g, 15.0 mmol) and 2-chlorophenothiazine (1.17 g, 5.00 mmol) in toluene (15.0 mL) was added tributyl(2-thienyl)tin (2.24 g, 1.90 mL, 6.00 mmol) and the reaction solution was stirred at 80 ºC for 24 h. After reaction mixture was cooled to room temperature, dichloromethane (15 mL) and H2O (15 mL) were added. Separated water phase was extracted with dichloromethane (15 mL) for 3 times. Combined organic layer was dried over MgSO4 (10 g) and concentrated under reduced pressure to afford the crude product as a brown solid. Crude was purified by column chromatography on silica-gel (hexane: EtOAc = 50 : 1 ~ 5 : 1 → dichloromethane) to afford 2-(thiophen-2-yl)-10H-phenothiazine as a yellow solid (990 mg, 3.51 mmol, 70%).
Completion of the reaction was confirmed by TLC (Hexane:EtOAc = 10:1, Rf: S.M.=0.28 T.M.=0.18) and GC.
1H NMR (400 MHz, CDCl3); δ 7.92 (brs, 1H), 7.42 (dd, J = 0.9, 5.0 Hz, 1H), 7.35 (dd, J = 0.9, 3.6 Hz, 1H), 7.08-7.13 (m, 2H), 6.94-7.03 (m, 4H), 6.73-6.82 (m, 2H).

To a 2-necked flask was charged with bis(dibenzylideneacetone)palladium (0) (36 mg, 0.0633 mmol, 1.5 mol%), XPhos (60 mg, 0.127 mmol, 3.0 mol%), sodium tert-butoxide (811 mg, 8.44 mmol, 2.0 equiv.) and toluene (5 mL) under nitrogen atmosphere. The mixture was stirred at room temperature for 5 min. 4-chlorotoluene (0.5 mL, 4.22 mmol, 1.0 equiv.), and morpholine (0.55 mL, 6.33 mmol, 1.5 equiv.) were added in one portion. The resulting mixture was stirred at reflux for 6 h. The reaction mixture was cooled to room temperature and quenched with water (10 mL). The organic layer was washed with water (10 mL), and brine (10 mL), dried with Na2SO4 (20 g) and then concentrated under reduced pressure. The crude product was purified by column chromatography on silica gel (hexane : ethyl acetate = 9 : 1) to afford the corresponding compound as an orange solid (700 mg, 94%).
Toluene was degassed by bubbling with nitrogen gas for 30 min.
The reaction mixture was monitored by GC.
1H NMR (400 MHz, CDCl3); δ 7.10 (d, J = 8.7 Hz, 2H), 6.84 (d, J = 8.7 Hz, 2H), 3.87 (t, J = 4.8 Hz, 4H), 3.11 (t, J = 4.8 Hz, 4H), 2.28 (s, 3H).
13C NMR (101 MHz, CDCl3); δ 149.1, 129.7, 129.5, 116.0, 66.9, 49.9, 20.4.
Das angeforderte SDB ist nicht verfügbar.
Bitte Kontaktieren Sie uns für mehr Informationen.
Ein Muster-AZ für dieses Produkt ist zur Zeit nicht verfügbar.
Das angeforderte Analysediagramm ist nicht verfügbar. Wir entschuldigen uns für die Unannehmlichkeiten.